Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | IL-13 | 35.5 | 44 | |
RA2159 | 3 | IL-13 | 39.5 | 62 | |||||||
N2586 | IGF-I | 100 | ug/mL | 3 | IL-13 | 49.0 | 74 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | IL-13 | 50.0 | 51 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-13 | 42.0 | 68 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-13 | 53.0 | 69 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-13 | 59.0 | 73 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | IL-13 | 48.0 | 65 | |
N2586 | 3 | IL-13 | 44.0 | 67 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | IL-13 | 32.5 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 43.5 | 56 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 41.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 35.0 | 49 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 32.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 36.0 | 51 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | IL-13 | 42.5 | 58 | ||||
N2586 | EGF | 100 | ng/mL | 3 | IL-13 | 40.0 | 68 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 49.0 | 86 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 50.0 | 47 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 52.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 48.0 | 69 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | IL-13 | 23.5 | 56 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | IL-13 | 30.0 | 49 | ||||
RA2159 | 3 | IL-13 | 33.5 | 66 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-13 | 35.0 | 49 |